Partial-Methylated HeyL Promoter Predicts the Severe Illness in Egyptian COVID-19 Patients.
Dis Markers
; 2022: 6780710, 2022.
Article
in En
| MEDLINE
| ID: mdl-35655915
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Repressor Proteins
/
Basic Helix-Loop-Helix Transcription Factors
/
COVID-19
Type of study:
Guideline
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Humans
Country/Region as subject:
Africa
Language:
En
Journal:
Dis Markers
Journal subject:
BIOQUIMICA
Year:
2022
Document type:
Article
Affiliation country:
Country of publication: